Evidence map›Paper›PMID 19470397›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2009

Silk-elastinlike recombinant polymers for gene therapy of head and neck cancer: from molecular definition to controlled gene expression.

Joshua Gustafson, Khaled Greish, Jordan Frandsen, Joseph Cappello, Hamidreza Ghandehari

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Protein-Engineered Functional Materials.Advanced healthcare materials · 2019
    Review
  12. The Utility of Silk-elastin Hydrogel as a New Material for Wound Healing.Plastic and reconstructive surgery. Global open · 2018
    Article
  13. Article
  14. Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Review
  15. In vivo evaluation of matrix metalloproteinase responsive silk-elastinlike protein polymers for cancer gene therapy.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Article
  16. 3B, a novel of photosensitizer, exhibited anti-tumor effects via mitochondrial apoptosis pathway in MCF-7 human breast carcinoma cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  17. Review
  18. Effect of shear on physicochemical properties of matrix metalloproteinase responsive silk-elastinlike hydrogels.Journal of controlled release : official journal of the Controlled Release Society · 2014
    Article
  19. Controlled release from recombinant polymers.Journal of controlled release : official journal of the Controlled Release Society · 2014
    Review
  20. Silk-based biomaterials for sustained drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Joshua GustafsonDepartment of Bioengineering, University of Utah, Salt Lake City, UT, 84108, USA; Utah Center for Nanomedicine, Nano Institute of Utah, University of Utah, Salt Lake City, UT 84108, USA.
Khaled Greish
Jordan Frandsen
Joseph Cappello
Hamidreza Ghandehari
University of Utah · USMarine Polymer Technologies (United States) · US

Funding

Engineering Polymers For Gene Therapy of Head CancerR01CA107621 · NCI · UNIVERSITY OF UTAH · PI GHANDEHARI, HAMID · 2005 to 2014
$2.5M
NCI NIH HHS R01 CA107621NCI NIH HHS R01-CA107621
6 · The paper itself

Abstract

Silk-elastinlike protein polymers (SELP's) are block copolymers of silk-like and elastin-like tandem repeats. With appropriate sequence and composition SELPs can be liquid at room temperature and form hydrogels at body temperature. The influence of polymer structure and concentration on biodegradation in vitro and controlled delivery of adenoviruses carrying reporter genes to head and neck tumors in vivo was evaluated using hydrogels made from three SELP analogs. SELP-815K, with eight silk and fifteen elastin units and a lysine (K) modified elastin, was compared to SELP-415K and SELP-47K. Hydrogels with higher silk content and concentration degraded at a slower rate compared to other analogs. Intratumoral injection of adenoviruses with SELPs enhanced gene expression in tumor tissue up to 10 fold compared to viral injection without polymer. Viruses delivered with SELP-815K at 4 wt.% polymer concentration showed the highest level of gene expression. Tumor to liver ratio of expression was up to 55 fold higher for SELP-mediated systems. This study demonstrates the influence of exquisite control over polymer structure using recombinant techniques on spatial and temporal control over adenoviral delivery and establishes the utility of SELP matrices as biodegradable systems for gene therapy of head and neck cancer.

Indexed as

AdenoviridaeAmino Acid SequenceAnimalsbeta-GalactosidaseCross-Linking ReagentsElastinGene ExpressionGenetic TherapyHead and Neck NeoplasmsHumansHydrogelsLac OperonLuminescenceMiceMice, NudeMolecular Sequence Databeta-GalactosidaseCross-Linking ReagentsElastinHydrogelsRecombinant ProteinsSilk

Identifiers

PMID19470397
PMCPMC2788012
OpenAlexW2075692927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.